LabCompass

Matthew Bohm

Biochemistry, Genetics and Molecular Biology · Indiana University

OpenAlex ORCID
Inflammatory Bowel DiseaseMicroscopic ColitisGastrointestinal motility and disordersEosinophilic EsophagitisClostridium difficile and Clostridium perfringens research

Publications

154

Citations

2,399

Est. group size

—

Recurring co-author estimate

Active years

61

Publishing since 1965

Research summary
AI-generated

Matthew Bohm conducts clinical research on inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis. The work focuses on real-world treatment effectiveness of biologic drugs, disease biomarkers, patient outcomes, and distinguishing IBD from conditions that resemble it. Studies often draw on large patient cohorts and consortium data.

Inflammatory bowel disease (Crohn's and ulcerative colitis)Biologic and small-molecule drug therapy effectivenessDisease biomarkers and patient-reported outcomesClinical diagnosis and IBD mimicsPatient cohort and healthcare utilization studies

Publication activity was high in the late 2010s (20-27 per year) but has slowed in recent years, averaging about 6 per year over the last five years.

Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026

Publication cadence
Publications per year over the last 10 years — averaging 6.0/year recently
2017: 10 publications172018: 27 publications27182019: 21 publications192020: 25 publications202021: 6 publications212022: 6 publications222023: 13 publications232024: 9 publications242025: 2 publications2526
Recent publications
Publishes in
  • Gastroenterology×41
  • The American Journal of Gastroenterology×21
  • Clinical Gastroenterology and Hepatology×9
  • Journal of Crohn s and Colitis×9
  • Inflammatory Bowel Diseases×8

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 11, 2026.

Claim or correct this profile